These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22908096)

  • 1. Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma.
    Kawaguchi A; Iwadate Y; Komohara Y; Sano M; Kajiwara K; Yajima N; Tsuchiya N; Homma J; Aoki H; Kobayashi T; Sakai Y; Hondoh H; Fujii Y; Kakuma T; Yamanaka R
    Clin Cancer Res; 2012 Oct; 18(20):5672-81. PubMed ID: 22908096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
    Ferreri AJ; Dell'Oro S; Capello D; Ponzoni M; Iuzzolino P; Rossi D; Pasini F; Ambrosetti A; Orvieto E; Ferrarese F; Arrigoni G; Foppoli M; Reni M; Gaidano G
    Br J Haematol; 2004 Sep; 126(5):657-64. PubMed ID: 15327516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
    Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
    Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of clinical characteristics and immunophenotypic biomarkers in 115 patients with primary central nervous system lymphoma.
    Chen BB; Xu XP; Shen L; Han TJ; Lin ZG; Chen Z; Kang H; Huang B; Lin GW
    Chin Med J (Engl); 2013 Feb; 126(3):482-7. PubMed ID: 23422111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of FOXP1 and cyclinE in primary central nervous system lymphoma and its significance].
    Shen L; Chen BB; Chen Z; Xu XP; Lin GW
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):648-52. PubMed ID: 23134861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implication of p27 expression in primary central nervous system lymphoma.
    Kunishio K; Nagao S
    Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.
    Abrey LE; Ben-Porat L; Panageas KS; Yahalom J; Berkey B; Curran W; Schultz C; Leibel S; Nelson D; Mehta M; DeAngelis LM
    J Clin Oncol; 2006 Dec; 24(36):5711-5. PubMed ID: 17116938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas.
    D'Haene N; Catteau X; Maris C; Martin B; Salmon I; Decaestecker C
    Br J Haematol; 2008 Feb; 140(4):402-10. PubMed ID: 18081894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients.
    Kasenda B; Rehberg M; Thürmann P; Franzem M; Veelken H; Fritsch K; Schorb E; Finke J; Lebiedz D; Illerhaus G
    Ann Hematol; 2012 Aug; 91(8):1257-64. PubMed ID: 22456893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas.
    Gonzalez-Aguilar A; Idbaih A; Boisselier B; Habbita N; Rossetto M; Laurenge A; Bruno A; Jouvet A; Polivka M; Adam C; Figarella-Branger D; Miquel C; Vital A; Ghesquières H; Gressin R; Delwail V; Taillandier L; Chinot O; Soubeyran P; Gyan E; Choquet S; Houillier C; Soussain C; Tanguy ML; Marie Y; Mokhtari K; Hoang-Xuan K
    Clin Cancer Res; 2012 Oct; 18(19):5203-11. PubMed ID: 22837180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
    Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
    Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a gene expression signature that predicts outcome in malignant glioma patients.
    Kawaguchi A; Yajima N; Komohara Y; Aoki H; Tsuchiya N; Homma J; Sano M; Natsumeda M; Uzuka T; Saitoh A; Takahashi H; Sakai Y; Takahashi H; Fujii Y; Kakuma T; Yamanaka R
    Int J Oncol; 2012 Mar; 40(3):721-30. PubMed ID: 22021018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
    Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
    Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in primary central nervous system lymphomas.
    Ferreri AJ; Reni M
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):629-49, vi. PubMed ID: 16083827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients.
    Sveen A; Ågesen TH; Nesbakken A; Meling GI; Rognum TO; Liestøl K; Skotheim RI; Lothe RA
    Clin Cancer Res; 2012 Nov; 18(21):6001-10. PubMed ID: 22991413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
    Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
    PLoS One; 2020; 15(2):e0229577. PubMed ID: 32101576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclooxygenase-2 and vascular endothelial growth factor in primary central nervous system lymphomas.
    Sugita Y; Komatani H; Ohshima K; Shigemori M; Nakashima A
    Oncol Rep; 2007 Sep; 18(3):617-22. PubMed ID: 17671709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.
    Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.